MicroPET imaging of a gastrin-releasing peptide receptor-positive tumor in a mouse model of human prostate cancer using a 64Cu-labeled bombesin analogue

Bioconjugate Chemistry

Volumn 14, Issue 4, 2003, Pages 756-763

  Rogers, Buck E ^a,c   Bigott, Heather M ^b   McCarthy, Deborah W ^b   Della Manna, Debbie ^a   Kim, Joonyoung ^b   Sharp, Terry L ^b   Welch, Michael J ^b  

^a The University of Alabama at Birmingham   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; GAMMA RAYS; MAMMALS; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; POSITRONS; TUMORS; UROLOGY;

ATHYMIC; BOMBESIN ANALOGUES; HUMAN PROSTATE CANCER; MICE MODELS; MICRO PETS; NUDE MICE; PEPTIDE RECEPTOR; POSITRON EMISSION; TOMOGRAPHIC IMAGING; TUMOUR LOCALIZATION;

PEPTIDES;

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; BOMBESIN; COPPER 64; GASTRIN RELEASING PEPTIDE RECEPTOR; PYRUVALDEHYDE BIS(N 4 METHYLTHIOSEMICARBAZONE) CU 64; RECEPTOR; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BINDING ASSAY; GAMMA SCINTIGRAPHY; HUMAN; HUMAN CELL; IMAGING; INTERNALIZATION; ISOTOPE LABELING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TUMOR LOCALIZATION;

ANIMALIA; MUS MUSCULUS;

EID: 0038455833     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc034018l     Document Type: Article

References (50)

1. Sunday, M. E., Kaplan, L. M., Motoyama, E., Chin, W. W., and Spindel, E. R. (1988) Gastrin-releasing peptide (mammalian bombesin) gene expression in health and disease. Lab. Invest. 59, 5-24.
2. Spindel, E. R., Giladi, E., Segerson, T. P., and Nagalla, S. (1993) Bombesin-like peptides: of ligands and receptors. Recent Prog. Horm. Res. 48, 365-391.
3. Moody, T. W., Carney, D. N., Cuttitta, F., Quattrocchi, K., and Minna, J. D. (1985) High affinity receptors for bombesin/ GRP-like peptides on human small cell lung cancer. Life Sci. 37, 105-113.
4. Radulovic, S., Miller, G., and Schally, A. V. (1991) Inhibition of growth of HT-29 human colon cancer xenografts in nude mice by treatment with bombesin/gastrin releasing peptide antagonist (RC-3095). Cancer Res. 51, 6006-6009.
5. Pinski, J., Schally, A. V., Halmos, G., Szepeshazi, K., and Groot, K. (1994) Somatostatin analogues and bombesin/ gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo. Cancer Res. 54, 5895-5901.
6. Qin, Y., Ertl, T., Cai, R. Z., Halmos, G., and Schally, A. V. (1994) Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro. Cancer Res. 54, 1035-1041.
7. 14] Bombesin(6-14). Clin. Cancer Res. 8, 1139-1146.
8. Von Schrenck, T., Heinz-Erian, P., Moran, T., Mantey, S. A., Gardner, J. D., and Jensen, R. T. (1989) Neuromedin B receptor in esophagus: Evidence for subtypes of bombesin receptors. Am. J. Physiol. 256, 747-758.
9. Fathi, Z., Corjay, M. H., Shapira, H., Wada, E., Benya, R., Jensen, R., Viallet, J., Sausville, E. A., and Battey, J. F. (1993) BRS-3: a novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells. J. Biol. Chem. 268, 5979-5984.
10. 13]bombesin distinct from the receptor for gastrin-releasing peptide: Identification of a fourth bombesin receptor subtype (BB4). Proc. Natl. Acad. Sci. U.S.A. 92, 6205-6209.
11. Cuttitta, F., Carney, D. N., Mulshine, J., Moody, T. W., Fedorko, J., Fischler, A., and Minna, J. D. (1985) Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 316, 823-826.
12. Kiaris, H., Schally, A. V., Nagy, A., Sun, B., Armatis, P., and Szepeshazi, K. (1999) Targeted cytotoxic analogue of bombesin/gastrin-releasing peptide inhibits the growth of H-69 human small-cell lung carcinoma in nude mice. Br. J. Cancer 81, 966-971.
13. Schally, A. V., Comaru-Schally, A. M., Nagy, A., Kovacs, M., Szepeshazi, K., Plonowski, A., Varga, J. L., and Halmos, G. (2001) Hypothalamic hormones and cancer. Front. Neuroendocrinol. 22, 248-291.
14. Bajo, A. M., Schally, A. V., Krupa, M., Hebert, F., Groot, K., and Szepeshazi, K. (2002) Bombesin antagonists inhibit growth of MDA-MB-435 estrogen-independent breast cancers and decrease the expression of the ErbB-2/HER-2 oncoprotein and c-jun and c-fos oncogenes. Proc. Natl. Acad. Sci. U.S.A. 99, 3836-3841.
15. Nagy, A., Armatis, P., Cai, R. Z., Szepeshazi, K., Halmos, G., and Schally, A. V. (1997) Design, synthesis, and in vitro evaluation of cytotoxic analogues of bombesin-like peptides containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin. Proc. Natl. Acad. Sci. U.S.A. 94, 652-656.
16. Safavy, A., Khazaeli, M. B., Qin, H., and Buchsbaum, D. J. (1997) Synthesis of bombesin analogues for radiolabeling with Rhenium-188. Cancer (Suppl) 80, 2354-2359.
17. Rogers, B. E., Curiel, D. T., Mayo, M. S., Laffoon, K. K., Bright, S. J., and Buchsbaum, D. J. (1997) Tumor localization of a radiolabeled bombesin analogue in mice bearing human ovarian tumors induced to express the gastrin releasing peptide receptor by an adenoviral vector. Cancer 80, 2419-2424.
18. 2: A new gastrin releasing peptide receptor (GRPr) targeting radiopharmaceutical. J. Labelled Compd. Radiopharm. 44, S706-S708.
19. 2. Nucl. Med. Biol. 29, 423-430.
20. Baidoo, K. E., Lin, K. S., Zhan, Y., Finley, P., Scheffel, U., and Wagner, H. N., Jr. (1998) Design, synthesis, and initial evaluation of high-affinity technetium bombesin analogues. Bioconjugate Chem. 9, 218-225.
21. Karra, S., Schibli, R., Gali, H., Katti, K., Hoffman, T., Higginbotham, C., Sieckman, G., and Volkert, W. (1999) 99mTc-labeling and in vivo studies of a bombesin analogue with a novel water-soluble dithiadiphosphine-based bifunctional chelating agent. Bioconjugate Chem. 10, 254-260.
22. Breeman, W. A. P., Hofland, L. J., de Jong, M., Bernard, B. F., Srinivasan, A., Kwekkeboom, D. J., Visser, T. J., and Krenning, E. P. (1999) Evaluation of radiolabeled bombesin analogues for receptor-targeted scintigraphy and radiotherapy. Int. J. Cancer 81, 658-665.
23. 4]bombesin, a new radio-ligand for bombesin-receptor scintigraphy. Int. J. Cancer 83, 657-663.
24. Van de Wiele, C., Dumont, F., Broecke, R. V., Oosterlinck, W., Cocquyt, V., Serreyn, R., Peers, S., Thornback, J., Slegers, G., and Dierckx, R. A. (2000) Technetium-99m RP527, a GRP analogue for visualization of GRP receptor-expressing malignancies: a feasibility study. Eur. J. Nucl. Med. 27, 1694-1699.
25. Van de Wiele, C., Dumont, F., Van Belle, S., Slegers, G., Peers, S. H., and Dierckx, R. A. (2001) Is there a role for agonist gastrin-releasing peptide receptor radioligands in tumour imaging? Nucl. Med. Commun. 22, 5-15.
26. 99mTc-RP527, a gastrin-releasing peptide (GRP) agonist for the visualization of GRP receptor-expressing malignancies. J. Nucl. Med. 42, 1722-1727.
27. 99mTc(I)-labeled bombesin analogue for imaging of gastrin releasing peptide receptor-positive tumors. Nucl. Med. Biol. 29, 553-560.
28. 99mTc-postlabeled high affinity bombesin analogue as a potential tumor imaging agent. Bioconjugate Chem. 13, 599-604.
29. 67Cu. Proc. Natl. Acad. Sci. U.S.A. 93, 6814-6818.
30. Anderson, C. J., Jones, L. A., Bass, L. A., Sherman, E. L. C., McCarthy, D. W., Cutler, P. D., Lanahan, M. V., Cristel, M. E., Lewis, J. S., and Schwarz, S. W. (1998) Radiotherapy, toxicity and dosimetry of copper-64-TETA-octreotide in tumor-bearing rats. J. Nucl. Med. 39, 1944-1951.
31. McCarthy, D. W., Shefer, R. E., Klinkowstein, R. E., Bass, L. A., Margeneau, W. H., Cutler, C. S., Anderson, C. J., and Welch, M. J. (1997) Efficient production of high specific activity 64Cu using a biomedical cyclotron. Nucl. Med. Biol. 24, 35-43.
32. Cherry, S., Shao, Y., Silverman, R., Meadors, K., Siegel, S., Chatziioannou, A., Young, J., Jones, W., Moyers, J., Newport, D., Boutenouchet, A., Farquhar, T., Andreaco, M., Paulus, M., Binkley, D., Nutt, R., and Phelps, M. (1997) MicroPET: A high-resolution PET scanner for imaging small animals. IEEE Trans. Nucl. Sci. 44, 1161-1166.
33. Defrise, M. P., Kinahan, D., Townsend, C., Michel, M., and Newport, D. (1997) Exact and approximate rebinning algorithms for 3-D PET data. IEEE Trans. Med. Imaging 16, 145-158.
34. 111In]-DTPA-D-Phel-octreotide to human ovarian tumor xenografts induced to express the somatostatin receptor subtype 2 using an adenoviral vector. Clin. Cancer Res. 5, 383-393.
35. Mathias, C. J., Welch, M. J., Perry, D. J., McGuire, A. H., Zhu, X., Connett, J. M., and Green, M. A. (1991) Investigation of copper-PTSM as a PET tracer for tumor blood flow. Int. J. Rad. Appl. Instrum. B 18, 807-811.
36. 111In-DTPA-D-Phel-octreotide in 194 carcinoid patients: Vienna University Experience, 1993 to 1998. J. Clin. Oncol. 18, 1331-1336.
37. 111In-labeled DOTA-conjugated rhenium-cyclized alpha-MSH analogues. J. Med. Chem. 45, 3048-3056.
38. Kwekkeboom, D. J., and Krenning, E. P. (2002) Somatostatin receptor imaging. Semin. Nucl. Med. 32, 84-91.
39. 125I-(Tyr4) bombesin by tumor cells. Prostate 25, 29-38.
40. Mantey, S., Frucht, H., Coy, D. H., and Jensen, R. T. (1993) Characterization of bombesin receptors using a novel, potent, radiolabeled antagonist that distinguishes bombesin receptor subtypes. Mol. Pharmacol. 43, 762-774.
41. 111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR. J. Nucl. Med. 41, 429-438.
42. Rogers, B. E., Anderson, C. J., Connett, J. M., Guo, L. W., Edwards, W. B., Sherman, E. L. C., Zinn, K. R., and Welch, M. J. (1996) Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: Biodistribution and metabolism. Bioconjugate Chem. 7, 511-522.
43. Bass, L. A., Wang, M., Welch, M. J., and Anderson, C. J. (2000) In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver. Bioconjugate Chem. 11, 527-532.
44. Luker, G. D., Sharma, V., Pica, C. M., Dahlheimer, J. L., Li, W., Ochesky, J., Ryan, C. E., Piwnica-Worms, H., and Piwnica-Worms, D. (2002) Noninvasive imaging of protein - protein interactions in living animals. Proc. Natl. Acad. Sci. U.S.A. 99, 6961-6966.
45. Liang, Q., Gotts, J., Satyamurthy, N., Barrio, J., Phelps, M. E., Gambhir, S. S., and Herschman, H. (2002) Noninvasive, repetitive, quantitative measurement of gene expression from a bicistronic message by positron emission tomography, following gene transfer with adenovirus. Mol. Ther. 6, 73-82.
46. 1-octreotate: A somatostatin analogue for labeling with metal and halogen radionuclides for cancer imaging and therapy. Bioconjugate Chem. 13, 721-728.
47. 3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors. Nucl. Med. Biol. 29, 147-157.
48. Fanger, B. O., Wade, A. C., and Cardin, A. D. (1991) Characterization of the murine pancreatic receptor for gastrin releasing peptide and bombesin. Reg. Pept. 32, 241-251.
49. Hajri, A., Koenig, M., Balboni, G., and Damge, C. (1996) Expression and characterization of gastrin-releasing peptide receptor in normal and cancerous pancreas. Pancreas 12, 25-35.
50. Krohn, K. A. (2001) The physical chemistry of ligand-receptor binding identifies some limitations to the analysis of receptor images. Nucl. Med. Biol. 28, 477-483.